High confidence · 49 reviews analyzed
Upset
Recent user voice shows a upset sentiment. Users appreciate clinical utility of the perioperative anticoagulant scheduling tool remains highly valued by medical professionals, but report forced subscription model revokes lifetime access previously purchased by long-term medical professional users and lack of grandfathering for legacy users creates significant friction and loss of trust in the brand.
Rating: 1.3
Reviews: 49
Confidence: high
How did the latest release land?
Overall
1.2/ 5
★★★★★
(578)Current version
1.3/ 5
+0.0 vs overall
★★★★★★
(362)Main signal post-update: clinical utility of the perioperative anticoagulant scheduling tool remains highly valued by medical professionals.
Limited review volume (49 reviews). Sentiment analysis will deepen as more data lands.